Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report, dated May 14, 2025, discloses a specific transaction in the company's own shares under its share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 820,380 ordinary shares
- Purchase Date: May 13, 2025
- Highest Price Paid: 406.30 pence per share
- Lowest Price Paid: 392.60 pence per share
- Volume Weighted Average Price: 397.17 pence per share
- Treasury Shares Held: 4,080,205
- Shares with Voting Rights: 9,011,009,299
Material Changes
Following the settlement of the repurchase, the company's registered share capital remains 9,015,089,504 ordinary shares of £0.01 each. The number of shares held as treasury shares increased to 4,080,205, resulting in a reduction of the total number of ordinary shares with voting rights to 9,011,009,299.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of a share transaction in compliance with the Market Abuse Regulation (Article 5(1)(b)).
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full breakdown of individual trades available via the London Stock Exchange link provided in the filing.
- Check the company's website for updated capital structure details and treasury share holdings.